Ilias D. Vachliotis

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review.

The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review.

Journal: Current obesity reports

Published: July 30, 2025

The potential role of adipokines and hepatokines in age-related ocular diseases.

The potential role of adipokines and hepatokines in age-related ocular diseases.

Journal: Metabolism open

Published: December 30, 2024

The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial.

The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 02, 2024

Osteokines in Nonalcoholic Fatty Liver Disease.

Osteokines in Nonalcoholic Fatty Liver Disease.

Journal: Current obesity reports

Published: August 21, 2024

Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease.

Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease.

Journal: Hormones (Athens, Greece)

Published: January 20, 2024

Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.

Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.

Journal: Cancers

Published: October 01, 2023

The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease.

The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease.

Journal: Current obesity reports

Published: June 20, 2023

Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.

Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.

Journal: Metabolism: clinical and experimental

Published: June 14, 2023

Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease.

Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease.

Journal: Current obesity reports

Published: March 29, 2023

Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy.

Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy.

Journal: Seminars in cancer biology

Published: January 12, 2023

Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications.

Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications.

Journal: Diabetes, obesity & metabolism

Published: March 21, 2022

Association between hepatic steatosis and fibrosis indices and dietary habits, physical activity, and quality of life.

Association between hepatic steatosis and fibrosis indices and dietary habits, physical activity, and quality of life.

Journal: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology

Published: October 04, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026